Search

everythinglearnresearchcommunity

for

Search:↓

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Certain immune cells help hair growth by regulating iron in the skin.

Circular RNA ERCC6 helps activate stem cells important for cashmere goat hair growth by interacting with specific molecules in an m6A modification-dependent way.

Murine cytomegalovirus does not cause alopecia areata in these mice.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Integrin α6 helps identify different neural crest cell types in the skin.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

IL-17-producing γδ T cells help improve bone healing.

Targeting NETs may help reduce fibrosis in Crohn's disease.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.